Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72804 record(s)

Req # A-2020-001190

Adverse Reaction Report (AER) for Hydrocortisone acetate / Pramoxine hydrochloride. Report number: E2B_00619078.

Organization: Health Canada

56 page(s)
January 2021

Req # A-2020-001312

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-111509-472, Update on COVID Related Funding Opportunities under the Health Care Policy and Strategies Program.

Organization: Health Canada

3 page(s)
January 2021

Req # A-2020-001323

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-113185-156.

Organization: Health Canada

13 page(s)
January 2021

Req # A-2020-001339

Adverse Reaction Report (AER) for DANAZOL. Report number: 000913416.

Organization: Health Canada

12 page(s)
January 2021

Req # A-2020-001342

Adverse Reaction Report (AER) for IRBESARTAN. Report number: 000911257.

Organization: Health Canada

1 page(s)
January 2021

Req # A-2020-001359

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-100086-400.

Organization: Health Canada

5 page(s)
January 2021

Req # A-2020-001447

Adverse Reaction Report (AER) for IPRATROPIUM BROMIDE. Report number: E2B_03079630.

Organization: Health Canada

37 page(s)
January 2021

Req # A-2020-001472

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123505-887, Priorities to Address Aging Information Technology.

Organization: Health Canada

7 page(s)
January 2021

Req # A-2020-00436

Please provide internal correspondences, e-mails and communications by Immigration Division adjudicators regarding vulnerable immigration detainees, including "Immigration Division - Member's Case Reports" (excluding personal…

Organization: Immigration and Refugee Board of Canada

237 page(s)
January 2021

Req # A-2020-01124

Please provide electronic copies of the written reasons for the following RPD decisions: TB7-04392; TB8-17781; TB8-19949; TB9-01394; TB9-02835; VB8-04562; TB9-04813; TB9-02164; VB8-04811; VB9-00362; MB7-18354; VB8-03742; MB7-21566; MB7-18975; TB8-…

Organization: Immigration and Refugee Board of Canada

243 page(s)
January 2021
Date modified: